X0306 4 2018-05-09 0 0000885978 U S PHYSICAL THERAPY INC /NV USPH 0001270356 READING CHRISTOPHER J 1300 W. SAM HOUSTON PKWY S. SUITE 300 HOUSTON TX 77042 1 1 0 0 Chief Executive Officer Common Stock 2018-05-09 4 S 0 13639 92.01 D 89828 D Common Stock 2018-05-10 4 S 0 8689 92.05 D 81139 D Common Stock 2018-05-11 4 S 0 2672 92.16 D 78467 D The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.10, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Includes 47,660 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.40, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. /s/ Christopher J Reading 2018-05-11